<?xml version="1.0" encoding="UTF-8"?>
<p id="Par32">Virus neutralization test (VNT) is considered as the gold standard for serological monitoring and efficacy evaluation of CSF vaccines. However, it has several limitations including time-consuming, requirement of cell culture, the need for live virus manipulation, and relatively expensive [
 <xref ref-type="bibr" rid="CR2">2</xref>, 
 <xref ref-type="bibr" rid="CR18">18</xref>â€“
 <xref ref-type="bibr" rid="CR21">21</xref>]. Here, we described a competitive ELISA (cELISA) developed with a neutralizing anti-E2 monoclonal antibody. This novel cELISA is a rapid, simple, safe and cost effective approach for detection of C-strain CSF vaccine-induced immune response.
</p>
